Protective effects of increasing vitamin E and A doses on cisplatin-induced oxidative damage to kidney tissue in rats

Urologia Internationalis

Volumn 75, Issue 4, 2005, Pages 340-344

  Dillioglugil, Meltem Ozlen ^a   Kir, Hale Maral ^a   Gulkac, Mehmet Dogan ^a   Kanli, Aylin Özon ^a   Ozdogan, Haci Kahya ^a   Acar, Oguz ^a   Dillioglugil, Ozdal ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Antioxidant; Cisplatin; Lipid peroxidation; Nephrotoxicity; Nitric oxide

Indexed keywords

ALPHA TOCOPHEROL; CISPLATIN; GLUTATHIONE; MALONALDEHYDE; NITRIC OXIDE; RETINOL; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; KIDNEY INJURY; KIDNEY PARENCHYMA; MALE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; RENAL PROTECTION; TISSUE INJURY;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CISPLATIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; GLUTATHIONE; KIDNEY; KIDNEY DISEASES; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME; VITAMIN D; VITAMIN E; VITAMINS;

EID: 28644450594     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089171     Document Type: Article

References (33)

1. Rosenberg B: Fundamental studies with cisplatin. Cancer 1985;55:2303-2316.
2. Weijl NI, Cleton FJ, Osanto S: Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat Rev 1997;23:209-240.
3. Kuhlmann MK, Burkhardt G, Kohler H: Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial Transplant 1997;12:2478-2480.
4. Yoshida M, Iizuka K, Terada A, Hara M, Nishijima H, Shimada A, Nakada K, Satoh Y, Akama Y: Prevention of nephrotoxicity of cisplatin by repeated oral administration of ebselen in rats. Tohoku J Exp Med 2000;191:209-220.
5. Mora L, Antunes LM, Francescato HD, Bianchi L: The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats. Pharmacol Res 2003;47:517-522.
6. Masuda H, Tanaka T, Takahama U: Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochem Biophys Res Commun 1994;203:1175-1180.
7. Matsushima H, Yonemura K, Ohishi K, Hishida A: The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. J Lab Clin Med 1998;131:518-526.
8. Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV: In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 1998;53:394-401.
9. Bogdanovic V, Bogdanovic G, Grubor-Lajsic G, Rudic A, Baltic VV: Effect of irradiation on enzymes of antioxidative defence system in L929 cell culture in the presence of α-tocopherol-acetate. Arch Oncol 2000;8:157-159.
10. Weijl NI, Hopman GD, Wipkink-Bakker A, Lentjes EG, Berger HM, Cleton FJ, Osanto S: Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Ann Oncol 1998;9:1331-1337.
11. Xu W, Liu LZ, Loizidou M, Ahmed M, Charles IG: The role of nitric oxide in cancer. Cell Res 2002;12:311-320.
12. Bakan N, Taysi S, Yilmaz O, Bakan E, Kuskay S, Uzun N, Gundogdu M: Glutathione peroxidase, glutathione reductase, Cu-Zn superoxide dismutase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serum of patients with chronic lymphocytic leukemia. Clin Chim Acta 2003;338:143-149.
13. Dean RT, Cheeseman KH: Vitamin E protects proteins against free radical damage in lipid environments. Biochem Biophys Res Commun 1987;148:1277-1282.
14. Liebler DC, Kling DS, Reed DJ: Antioxidant protection of phospholipid bilayers by α-tocopherol. Control of α-tocopherol status and lipid peroxidation by ascorbic acid and glutathione. J Biol Chem 1986;261:12114-12119.
15. Palozza P, Krinsky NI: Antioxidant effects of carotenoids in vivo and in vitro: an overview. Methods Enzymol 1992;213:403-420.
16. Willett WC, McMahon B: Diet and cancer - an overview. N Engl J Med 1984;310:633-638.
17. Buege JA, Aust SD: Microsomal lipid peroxidation. Methods Enzymol 1978;52:302-310.
18. Ellman GL: Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-77.
19. Sun Y, Oberley LW, Li Y: A simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34;497-500.
20. Cortas NK, Wakid NW: Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990;36:1440-1443.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
22. Naziroglu M, Karaoglu A, Aksoy AO: Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology 2004;195:221-230.
23. Yildirim Z, Sogut S, Odaci E, Iraz M, Ozyurt H, Kotuk M, Akyol O: Oral erdosteine administration attenuates cisplatin-induced renal tubular damage in rats. Pharmacol Res 2003;47:149-156.
24. Anand AJ, Bashey B: Newer insights into cisplatin nephrotoxicity. Ann Pharmacother 1993;27:1519-1525.
25. Sayed-Ahmed MM, Eissa MA, Kenawy SA, Mostafa N, Calvani M, Osman AM: Progression of cisplatin-induced nephrotoxicity in a carnitine-depleted rat model. Chemotherapy 2004;50:162-170.
26. Zhang JG, Lindup WE: Differential effects of cisplatin on the production of NADH-dependent superoxide and the activity of antioxidant enzymes in rat renal cortical slices in vitro. Pharmacol Toxicol 1996;79:191-198.
27. al-Harbi MM, Osman AM, al-Gharably NM, al-Bekairi AM, al-Shabanah OA, Sabah DM, Raza M: Effect of desferrioxamine on cisplatin-induced nephrotoxicity in normal rats. Chemotherapy 1995;41:448-454.
28. Sangeetha P, Das UN, Koratkar R, Suryaprabha P: Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Radic Biol Med 1990;8:15-19.
29. Antunes LM, Darin JD, Bianchi L: Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats. Pharmacol Res 2001;43:145-150.
30. Goligorsky MS, Brodsky SV, Noiri E: Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int 2002;61:855-861.
31. Peresleni T, Noiri E, Bahou WF, Goligorsky MS: Antisense oligodeoxynucleotides to inducible NO synthase rescue epithelial cells from oxidative stress injury. Am J Physiol 1996;270:971-977.
32. Gossmann J, Radounikli A, Bernemann A, Schellinski O, Raab HP, Bickeboller R, Scheuermann EH: Pathophysiology of cyclosporine-induced nephrotoxicity in humans: a role for nitric oxide? Kidney Blood Press Res 2001;24:111-115.
33. Packer L, Landvick S: Vitamin E in biological systems; in Emerit I, Packer L, Auclair C (eds): Antioxidants in Therapy and Preventive Medicine. New York, Plenum Press, 1990, pp 93-104.